
UCB Canada Inc.

UCB Canada Inc.
3 sessions, November 12–13At UCB Canada, we believe that all Canadians deserve to live the best life that they can – as free as possible from the burdens and challenges of disease.
We work tirelessly not only to bring innovative medicines to patients but also to be agents of change in our healthcare system. With the help of patients, caregivers, government, policymakers and advocacy groups, we strive to meet unmet patient needs, improve patient outcomes, and ensure viable and sustainable access for all.
With decades of scientific excellence behind us, we are driven to explore the furthest reaches with those who live with severe diseases lighting our way and holding us true to our purpose – ensuring that we always see people first and not just the disease.
We are driven by science and inspired by patients. We are UCB Canada.
Sessions at Dermatology Update — Fall 2026
3 sessions

UCB Psoriasis Consultancy Meeting

Why Stop at HiSCR50?
Join Dr. Lima and Dr. Colantonio as they discuss the evolving treatment paradigm in hidradenitis suppurativa (HS). Through a review of current evidence and clinical experience, the session will examine the importance of striving for deeper disease control, intervening earlier in the disease course, and the potential role of bimekizumab in advancing the standard of care for patients with HS.
- Recognize the importance of aiming for a higher threshold of treatment success to ensure deeper disease control
- Understand the need for earlier and more effective treatment to prevent irreversible tissue and psychological damage
- Illustrate the role of bimekizumab in the pursuit of raising the standard of care in HS
